Related Experiment Video
Updated: May 19, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain
1Department of Medicine and Alimentary Pharmabiotic Centre, University College Cork, National University of Ireland, Cork, Ireland. F.Shanahan@ucc.ie
Abstract:
Ulcerative colitis and Crohn's disease, collectively known as inflammatory bowel disease, represent the heterogeneous outcome of three colliding influences: genetic risk factors, environmental modifiers, and immune effector mechanisms of tissue injury. The nature of these inputs is complex, with each having distinct and overlapping contributions to ulcerative colitis and Crohn's disease. Identification of specific genetic risk factors has improved the understanding of specific pathways to disease, but the primacy of environmental or lifestyle factors linked to changes in the gut microbiota, particularly in early life, is increasingly evident. Clarification of the molecular basis of host-microbe interactions in health and in susceptible individuals promises novel therapeutic strategies.
Related Concept Videos
Functions of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
Microbiota of the Stomach and Small Intestine
Microbiota of the Large Intestine
Introduction to the Human Microbiota
Inflammatory Bowel Disease I: Introduction
